Stock data
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB) reported net income of -US$21.79M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$22.98M | -US$21.79M | — |
| 2024 | — | — | -US$51.78M | -US$44.58M | — |
| 2023 | — | — | -US$38.96M | -US$42.77M | — |
| 2022 | — | — | -US$28.81M | -US$28.60M | — |
| 2021 | — | — | -US$24.13M | -US$24.12M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$6.93M | — |
| 2026-03-31 | — | -US$5.65M | — |
| 2025-12-31 | — | -US$5.30M | — |
| 2025-09-30 | — | -US$4.44M | — |
| 2025-06-30 | — | -US$5.45M | — |
| 2025-03-31 | — | -US$6.60M | — |
| 2024-12-31 | — | -US$2.36M | — |
| 2024-09-30 | — | -US$14.66M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.